Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Summary
The purpose of this study is to collect blood samples, as well as tumor tissue for genetic analysis. The collection of samples will allow the creation of a plasma bank. Targeted individuals are cancer patients of all types, treated with immunotherapy or targeted therapy. Immunotherapy or targeted agents will be administered according to standard of care and reimbursement modalities in Belgium. Targeted agents will be administered according to manufacturer's instructions. With the aim to identify predictive markers of response to treatment or possible resistance mechanism, the plasma samples and the tumor samples will be used for genetic analysis, for example but not limited to, whole exome sequencing. This may lead to the discovery of some germinal mutations implicated in other diseases than cancer.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2018-07-11
Completion Date
2028-05-01
Last Updated
2023-12-11
Healthy Volunteers
No
Conditions
Interventions
Immunotherapeutic Agent
Immunotherapy will be administered according to standard of care and reimbursement modalities in Belgium.
Molecular Target
Targeted agents will be administered according to standard of care and reimbursement modalities in Belgium. Targeted agents will be administered according to manufacturer's instructions.
Locations (1)
Cliniques Universitaires Saint-Luc
Brussels, Belgium